Today’s AI Top Pick: TMDX

7/23/2026 · Highly Shorted Turnaround Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted Turnaround Deep RotationTMDXBUY NOW8.6 / 107/23/2026

TransMedics (TMDX) is the cleanest confluence of fundamentals AND forecast tape on this list. On fundamentals it clears the bar: trailing PE 16.34, ROE 45.22%, profit margin 27.04%, sales YoY +30.24%, EPS next year growth 70.61%, and analyst recom 1.64 with 60.1% target upside. Unlike most of this deep-rotation pool, TMDX is actually profitable — profit margin 27% is the highest among any name here with a positive fundamental_score above 6, and it is not a story stock resting on hope. The tape lines up. Bullish probability 1.0, near_term_bullish 0.6, and forecasts stack cleanly: 1d fc_short +53.79% / fc_mid +60.13% / fc_long +57.57%, 4h fc_short +46.12% / fc_mid +47.54%, and 1h fc_mid +24.99% / fc_long +32.26%. Critically, this is NOT extended: 1h position_in_range 25%, 4h 67.25%, 1d 49.25%, 1wk only 13.25% — you are buying in the middle of the intraday range, well off the 1wk drawdown of -44.45%. This is exactly the shape you want in a turnaround: a beaten-down leader where near-term structure has firmed and multi-timeframe forecasts agree. Headline check: Evercore lowered its target on 7/6 but maintained Outperform at $90, and the 7/3 Motley Fool piece framed it as a long-duration MedTech growth story. No dilution, no regulatory bomb, no short-seller report. Compare to the alternatives: PSIX's 1d forecasts are even bigger (+79/+106/+104%) but its 1wk forecasts are negative (-11.9/-31.6/-37.62) and 1h is pinned at 100% of range — worse entry, weaker MTF agreement. MNDY has monster weekly forecasts (+127/+180%) but its 1h is at the top (pos 100) and just announced a 20% headcount cut, which is a mixed signal into an uncertain restructure. CELH has near_term_bullish of only 0.2 and 1h is at 96.67% of range — you'd be chasing. Today is the right entry because TMDX offers you 1h positioning in the lower third of the range while 4h/1d forecasts are already turning up hard. Waiting for a deeper pullback risks missing the base-breakout in a name with prob 1.0 and 60% analyst upside — the setup is asymmetric right here.

Entry zone

$70.50–$72.50 (buy today into current $72 or on any dip to the 4h VWAP zone)

Stop loss

$64.50 (below the 1wk drawdown low band; ~10% risk, invalidates the reversal thesis)

First target

$88–$90 (aligns with Evercore $90 PT and the 1d fc_short +53.79% mapping to ~$110 conservatively cut to intermediate resistance)

Longer target

$110–$115 (1d/4h fc_mid +60% and analyst 60.1% upside path)

Risks

Short float 23.68% — squeeze cuts both ways; adverse organ-transplant volume data could trigger sharp downside
1wk drawdown -44.45% and pos_in_range 13.25% mean the weekly trend is still broken; a failure at $65 opens a re-test of the annual low
Recent Evercore price-target cut to $90 (from higher) signals sell-side is trimming expectations even while rated Outperform
Debt/Equity 1.75 with a capital-intensive OCS platform — any macro tightening pressures the growth multiple (fwdPe 23.14)
Institutional ownership 108.75% (heavy crowding) means positioning unwind risk if any Q3 print disappoints

Honorable mentions

PSIXCheapest name on the board (PE 7.49, fwdPe 8.66) with ROE 75.67% and profit margin 14.28%; 1d forecasts +79/+106/+104% and prob 1.0. Only reason it's #2: 1h at 100% of range (chase risk) and 1wk forecasts turn negative (-11.9/-31.6/-37.62).

MNDYEnormous weekly forecast magnitude (+127.71 / +179.73), fundamental score 6.5, PEG 1.12, prob 1.0. Held back by 1h pinned at pos 100 and this week's headline of a 20% layoff — bullish AI restructure narrative but execution risk is real.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	TMDX	BUY NOW	8.6	Profitable turnaround (27% margins, 45% ROE) with MTF forecast agreement (+46/+53/+60%) and 1h/1d positioning in mid-range — cleanest setup on the board.
2	PSIX	BUY PULLBACK	8.1	Deep value (PE 7.49, ROE 75.67%) with monster daily forecasts +79/+106/+104%, but 1h at top of range and 1wk forecasts negative — wait for a dip to $30.
3	MNDY	BUY PULLBACK	7.6	Weekly forecasts +128/+180% and prob 1.0, but 1h at pos 100 and 20% layoff news needs to settle first.
4	PGY	BUY PULLBACK	7.0	Best pure fundamentals (fwdPe 8.67, PEG 0.20, ROE 22.7%, recom 1.0) but weekly forecast turns sharply negative (-30/-43/-48%).
5	WING	WAIT	6.7	Prob 1.0, 1d forecast +23/+72/+74, but earnings next week is a binary event — no reason to add risk pre-print.
6	CWH	BUY PULLBACK	6.5	1wk forecast +105/+199/+204% is off the charts but debt/eq 19.03 and negative margins make this a speculative lotto — small size only.
7	KVYO	BUY NOW	6.3	Prob 1.0, near_term 0.8, 1d fc_mid +30/+38, PEG 0.66, recom 1.17 — solid secondary buy.
8	CELH	BUY PULLBACK	6.1	Best fundamental_score (8) but 1h pos 96.67 and near_term 0.2 — don't chase into $28.47.
9	QXO	BUY PULLBACK	5.9	Recom 1.13 and 1d forecast +28/+46/+39, but 1wk still broken (-36% recent) and near_term 0.
10	BRZE	WAIT	5.5	Bullish_prob 0 despite JPM raising PT to $35; forecasts modest and model disagrees with the sellside.
11	EYE	BUY PULLBACK	5.4	Multi-TF green in 1h/4h/1d but 1wk forecasts negative (-6/-8/-2%); wait for a base.
12	ASST	BUY NOW	5.2	Prob 1.0, 4h/1d forecasts +36/+50/+64%, positive TD Cowen note; small cap crypto-treasury story with narrative tailwind.
13	TTAN	WAIT	4.9	Prob null, 1h fc_short/mid/long all negative (-13/-10/-8%); wait for signal to clarify.
14	ZENA	BUY PULLBACK	4.8	1d forecast +75/+119/+152% with defense demos catalyst, but micro-cap and no fundamentals cushion.
15	PDYN	BUY NOW	4.7	USAF contract expansion (+$2.9M) and 1h/4h/1d forecasts +25–36%; small size due to profitability drag.
16	ASPI	BUY PULLBACK	4.6	Near_term 1.0 and 1d forecast +21/+71/+55, but 1wk forecasts negative and 1h pos 0 — knife-catch risk.
17	CRWV	WAIT	4.5	Prob null and fund score -0.25; strong AI narrative but too binary at 1h pos here.
18	MP	WAIT	4.4	Needham buy but PT lowered; 1wk forecasts turn negative (-26/-41) — rally exhausted for now.
19	INV	BUY PULLBACK	4.2	Massive forecast magnitudes but 1d recent -35% shows the trend is still bleeding.
20	RDW	WAIT	4.0	Prob 1 but near_term 0.2 and long-horizon forecasts negative on 4h/1wk; wait for reset.
21	KULR	WAIT	3.8	Mixed forecasts and 1d fc_short/mid negative (-6/-15%); profit margin -383% is disqualifying at size.
22	MBRX	AVOID	3.6	Trial data missed significance (-25% on 6/30); positive spin from CEO isn't enough to override the readout.
23	COSM	AVOID	3.3	1wk forecasts -75/-81/-89% and $13M mkt cap; buyback news doesn't offset the collapse in longer-horizon signal.
24	TNXP	WAIT	3.2	Only 1d tf available and near_term 0; not enough signal despite Medicare coverage news.
25	PROP	AVOID	3.1	Debt/eq 1222 and ROE -700%; 1wk forecasts negative; balance sheet risk too high.
26	SAIL	AVOID	3.0	1h forecasts all negative (-8/-10/-8%) and insider selling headline; setup is broken.
27	DFDV	AVOID	2.8	1d fc_short -6.6 and 1wk -46/-31/-50%; DisclaimerCoin leadership change is a red flag.
28	FLWS	AVOID	2.6	Forecasts flat-to-negative across all TFs; sales YoY -9.53% and margins negative.
29	UPXI	AVOID	2.5	PT lowered by Cantor; incomplete signal set and profit margin -874%.
30	PCT	AVOID	2.3	P/S 114, D/E 99.58, profit margin -2215% — no news catalyst can rescue this balance sheet.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord